121 related articles for article (PubMed ID: 27515006)
1. MicroRNA and target gene expression based clustering of oral cancer, precancer and normal tissues.
Roy R; Singh R; Chattopadhyay E; Ray A; Sarkar N; Aich R; Paul RR; Pal M; Roy B
Gene; 2016 Nov; 593(1):58-63. PubMed ID: 27515006
[TBL] [Abstract][Full Text] [Related]
2. A quest for miRNA bio-marker: a track back approach from gingivo buccal cancer to two different types of precancers.
De Sarkar N; Roy R; Mitra JK; Ghose S; Chakraborty A; Paul RR; Mukhopadhyay I; Roy B
PLoS One; 2014; 9(8):e104839. PubMed ID: 25126847
[TBL] [Abstract][Full Text] [Related]
3. Identification of Gene and MicroRNA Signatures for Oral Cancer Developed from Oral Leukoplakia.
Zhu G; He Y; Yang S; Chen B; Zhou M; Xu XJ
Biomed Res Int; 2015; 2015():841956. PubMed ID: 26064958
[TBL] [Abstract][Full Text] [Related]
4. Expression deregulation of mir31 and CXCL12 in two types of oral precancers and cancer: importance in progression of precancer and cancer.
Chattopadhyay E; Singh R; Ray A; Roy R; De Sarkar N; Paul RR; Pal M; Aich R; Roy B
Sci Rep; 2016 Sep; 6():32735. PubMed ID: 27597234
[TBL] [Abstract][Full Text] [Related]
5. Altered microRNA expression profile with miR-27b down-regulation correlated with disease activity of oral lichen planus.
Zhang WY; Liu W; Zhou YM; Shen XM; Wang YF; Tang GY
Oral Dis; 2012 Apr; 18(3):265-70. PubMed ID: 22077423
[TBL] [Abstract][Full Text] [Related]
6. Expression of miRNAs Targeting mTOR and S6K1 Genes of mTOR Signaling Pathway Including miR-96, miR-557, and miR-3182 in Triple-Negative Breast Cancer.
Razaviyan J; Hadavi R; Tavakoli R; Kamani F; Paknejad M; Mohammadi-Yeganeh S
Appl Biochem Biotechnol; 2018 Dec; 186(4):1074-1089. PubMed ID: 29862445
[TBL] [Abstract][Full Text] [Related]
7. miR-150-5p inhibits hepatoma cell migration and invasion by targeting MMP14.
Li T; Xie J; Shen C; Cheng D; Shi Y; Wu Z; Zhan Q; Deng X; Chen H; Shen B; Peng C; Li H; Zhu Z
PLoS One; 2014; 9(12):e115577. PubMed ID: 25549355
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA expression profiling and functional annotation analysis of their targets associated with the malignant transformation of oral leukoplakia.
Maimaiti A; Abudoukeremu K; Tie L; Pan Y; Li X
Gene; 2015 Mar; 558(2):271-7. PubMed ID: 25576219
[TBL] [Abstract][Full Text] [Related]
9. microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.
Zhao JJ; Lin J; Lwin T; Yang H; Guo J; Kong W; Dessureault S; Moscinski LC; Rezania D; Dalton WS; Sotomayor E; Tao J; Cheng JQ
Blood; 2010 Apr; 115(13):2630-9. PubMed ID: 20086245
[TBL] [Abstract][Full Text] [Related]
10. Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing.
Chang YY; Kuo WH; Hung JH; Lee CY; Lee YH; Chang YC; Lin WC; Shen CY; Huang CS; Hsieh FJ; Lai LC; Tsai MH; Chang KJ; Chuang EY
Mol Cancer; 2015 Feb; 14():36. PubMed ID: 25888956
[TBL] [Abstract][Full Text] [Related]
11. Relationship between microRNA expression levels and histopathological features of dysplasia in oral leukoplakia.
Brito JA; Gomes CC; Guimarães AL; Campos K; Gomez RS
J Oral Pathol Med; 2014 Mar; 43(3):211-6. PubMed ID: 24020903
[TBL] [Abstract][Full Text] [Related]
12. Salivary mir-27b Expression in Oral Lichen Planus Patients: A Series of Cases and a Narrative Review of Literature.
Stasio DD; Mosca L; Lucchese A; Cave DD; Kawasaki H; Lombardi A; Porcelli M; Caraglia M
Curr Top Med Chem; 2019; 19(31):2816-2823. PubMed ID: 31755392
[TBL] [Abstract][Full Text] [Related]
13. miRNA expression patterns in chemoresistant breast cancer tissues.
Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H
Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164
[TBL] [Abstract][Full Text] [Related]
14. Uncovering Direct Targets of MiR-19a Involved in Lung Cancer Progression.
Yamamoto K; Ito S; Hanafusa H; Shimizu K; Ouchida M
PLoS One; 2015; 10(9):e0137887. PubMed ID: 26367773
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B.
Fabbri M; Garzon R; Cimmino A; Liu Z; Zanesi N; Callegari E; Liu S; Alder H; Costinean S; Fernandez-Cymering C; Volinia S; Guler G; Morrison CD; Chan KK; Marcucci G; Calin GA; Huebner K; Croce CM
Proc Natl Acad Sci U S A; 2007 Oct; 104(40):15805-10. PubMed ID: 17890317
[TBL] [Abstract][Full Text] [Related]
16. A Screen for Epigenetically Silenced microRNA Genes in Gastrointestinal Stromal Tumors.
Isosaka M; Niinuma T; Nojima M; Kai M; Yamamoto E; Maruyama R; Nobuoka T; Nishida T; Kanda T; Taguchi T; Hasegawa T; Tokino T; Hirata K; Suzuki H; Shinomura Y
PLoS One; 2015; 10(7):e0133754. PubMed ID: 26214687
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of interleukin-22 and its targeting microRNAs in oral lichen planus: a preliminary study.
Shen Z; Du G; Zhou Z; Liu W; Shi L; Xu H
J Oral Pathol Med; 2016 Aug; 45(7):523-7. PubMed ID: 26711064
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA expression profiling and Notch1 and Notch2 expression in minimal deviation adenocarcinoma of uterine cervix.
Lee H; Kim KR; Cho NH; Hong SR; Jeong H; Kwon SY; Park KH; An HJ; Kim TH; Kim I; Yoon HK; Suh KS; Min KO; Choi HJ; Park JY; Yoo CW; Lee YS; Lee HJ; Lee WS; Park CS; Lee Y;
World J Surg Oncol; 2014 Nov; 12():334. PubMed ID: 25381598
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-200b inhibits the proliferation of hepatocellular carcinoma by targeting DNA methyltransferase 3a.
Li XY; Feng XZ; Tang JZ; Dong K; Wang JF; Meng CC; Wang J; Mo YW; Sun ZW
Mol Med Rep; 2016 May; 13(5):3929-35. PubMed ID: 26986232
[TBL] [Abstract][Full Text] [Related]
20. Abberent expression of oncogenic and tumor-suppressive microRNAs and their target genes in human adenocarcinoma alveolar basal epithelial cells.
Tafsiri E; Darbouy M; Shadmehr MB; Cho WC; Karimipoor M
J Cancer Res Ther; 2016; 12(1):395-400. PubMed ID: 27072269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
